A detailed history of Bahl & Gaynor Inc transactions in Mesa Laboratories Inc stock. As of the latest transaction made, Bahl & Gaynor Inc holds 8,986 shares of MLAB stock, worth $822,039. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,986
Previous 8,988 0.02%
Holding current value
$822,039
Previous $941,000 4.78%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$90.62 - $114.1 $181 - $228
-2 Reduced 0.02%
8,986 $986,000
Q4 2023

Feb 02, 2024

SELL
$84.55 - $115.06 $3,973 - $5,407
-47 Reduced 0.52%
8,988 $941,000
Q3 2023

Nov 03, 2023

BUY
$104.28 - $143.36 $406,900 - $559,390
3,902 Added 76.02%
9,035 $949,000
Q2 2023

Aug 14, 2023

SELL
$125.33 - $184.35 $1,127 - $1,659
-9 Reduced 0.18%
5,133 $659,000
Q1 2023

May 03, 2023

BUY
$163.15 - $203.76 $46,987 - $58,682
288 Added 5.93%
5,142 $898,000
Q4 2022

Feb 10, 2023

BUY
$118.55 - $188.84 $575,441 - $916,629
4,854 New
4,854 $806,000
Q1 2022

May 12, 2022

SELL
$248.18 - $329.02 $1.39 Million - $1.84 Million
-5,588 Closed
0 $0
Q4 2021

Feb 10, 2022

SELL
$295.95 - $332.41 $12,725 - $14,293
-43 Reduced 0.76%
5,588 $1.83 Million
Q3 2021

Nov 15, 2021

SELL
$266.92 - $322.44 $813,038 - $982,152
-3,046 Reduced 35.1%
5,631 $1.7 Million
Q2 2021

Aug 06, 2021

SELL
$235.0 - $272.85 $779,965 - $905,589
-3,319 Reduced 27.67%
8,677 $2.35 Million
Q1 2021

May 11, 2021

SELL
$243.02 - $297.01 $296,727 - $362,649
-1,221 Reduced 9.24%
11,996 $2.92 Million
Q4 2020

Feb 02, 2021

BUY
$258.4 - $289.99 $48,837 - $54,808
189 Added 1.45%
13,217 $3.79 Million
Q3 2020

Nov 12, 2020

SELL
$211.1 - $255.87 $81,484 - $98,765
-386 Reduced 2.88%
13,028 $3.32 Million
Q2 2020

Aug 13, 2020

SELL
$208.55 - $264.25 $68,404 - $86,674
-328 Reduced 2.39%
13,414 $2.91 Million
Q1 2020

May 26, 2020

BUY
$190.69 - $270.25 $2.62 Million - $3.71 Million
13,742 New
13,742 $3.11 Million
Q1 2020

May 15, 2020

SELL
$190.69 - $270.25 $2.58 Million - $3.66 Million
-13,525 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$213.21 - $251.5 $12,792 - $15,090
60 Added 0.45%
13,525 $3.37 Million
Q3 2019

Nov 14, 2019

BUY
$206.69 - $258.29 $4,340 - $5,424
21 Added 0.16%
13,465 $3.2 Million
Q2 2019

Aug 12, 2019

BUY
$185.45 - $260.0 $55,264 - $77,480
298 Added 2.27%
13,444 $3.28 Million
Q1 2019

May 13, 2019

BUY
$204.75 - $240.24 $64,086 - $75,195
313 Added 2.44%
13,146 $3.03 Million
Q4 2018

Feb 12, 2019

SELL
$171.0 - $221.34 $162,963 - $210,937
-953 Reduced 6.91%
12,833 $2.67 Million
Q3 2018

Nov 09, 2018

BUY
$181.0 - $222.93 $58,463 - $72,006
323 Added 2.4%
13,786 $2.56 Million
Q2 2018

Aug 14, 2018

SELL
$142.4 - $211.08 $1.88 Million - $2.78 Million
-13,172 Closed
0 $0
Q1 2018

May 11, 2018

BUY
$124.77 - $152.86 $90,707 - $111,129
727 Added 5.84%
13,172 $1.96 Million
Q4 2017

Feb 13, 2018

SELL
$124.3 - $160.83 $12,430 - $16,083
-100 Reduced 0.8%
12,445 $1.55 Million
Q3 2017

Nov 13, 2017

BUY
$128.64 - $149.96 $239,913 - $279,675
1,865 Added 17.46%
12,545 $1.87 Million
Q2 2017

Aug 11, 2017

BUY
N/A
1,895 Added 21.57%
10,680 $1.53 Million
Q2 2017

Aug 10, 2017

BUY
N/A
8,785
8,785 $1.08 Million

Others Institutions Holding MLAB

About MESA LABORATORIES INC


  • Ticker MLAB
  • Exchange NASDAQ
  • Sector Technology
  • Industry Scientific & Technical Instruments
  • Shares Outstandng 5,317,270
  • Market Cap $486M
  • Description
  • Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the ...
More about MLAB
Track This Portfolio

Track Bahl & Gaynor Inc Portfolio

Follow Bahl & Gaynor Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.